Tag: immuno-oncology
Angelini Ventures invests into extended €75.8 million ($82
Angelini Ventures joins syndicate of top-tier international healthcare investors in Nouscom’s Series C financing roundFinancing will enable Nouscom to continue advancing the clinical development...